Confirm a stable target identifier before relying on this context across project surfaces.
CHEMBL612558 Target Snapshot
ADMET · ADMET
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Confirm a stable target identifier before relying on this context across project surfaces.
ADMET
Review this target as ADMET.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats ADMET as ChEMBL target CHEMBL612558. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether ADMET still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | ADMET |
| Target Type | ADMET |
| Organism | None |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
How to read this target
Review this target as ADMET.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL185043 | 11.0 | IC50 | 0.01 | Preclinical |
| CHEMBL187738 | 11.0 | IC50 | 0.01 | Preclinical |
| CHEMBL188103 | 11.0 | IC50 | 0.01 | Preclinical |
| CHEMBL1643094 | 10.92 | EC50 | 0.012 | Preclinical |
| CHEMBL43136 | 10.8 | EC50 | 0.016 | Preclinical |
| CHEMBL68131 | 10.8 | Kd | 0.01585 | Preclinical |
| CHEMBL608886 | 10.77 | IC50 | 0.017 | Preclinical |
| CHEMBL411735 | 10.7 | IC50 | 0.02 | Preclinical |
| CHEMBL1643090 | 10.6 | EC50 | 0.025 | Preclinical |
| CHEMBL449897 | 10.6 | IC50 | 0.0253 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
ADME — 123,718 assays, 5,793 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 70,506 | 18 | 7.0 |
| cell-based format | 17,402 | 5,101 | 5.2 |
| assay format | 11,866 | 622 | 5.9 |
| microsome format | 11,419 | 7 | 5.4 |
| cell-free format | 6,885 | 3 | 4.8 |
| tissue-based format | 3,915 | 40 | 6.0 |
| subcellular format | 1,323 | 2 | 6.9 |
| mitochondrion format | 259 | 0 | — |
| cell membrane format | 129 | 0 | — |
| small-molecule physicochemical format | 14 | 0 | — |
Toxicity — 26,592 assays, 421 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 18,862 | 3 | 5.5 |
| assay format | 3,463 | 21 | 5.2 |
| cell-based format | 2,908 | 361 | 5.1 |
| tissue-based format | 825 | 16 | 5.5 |
| subcellular format | 467 | 0 | — |
| microsome format | 29 | 0 | — |
| cell-free format | 20 | 0 | — |
| cell membrane format | 9 | 0 | — |
| mitochondrion format | 9 | 20 | 4.7 |
Functional — 1,864 assays, 1,334 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 734 | 581 | 5.9 |
| cell-based format | 708 | 713 | 5.9 |
| organism-based format | 266 | 0 | — |
| cell-free format | 61 | 34 | 6.5 |
| tissue-based format | 61 | 6 | 4.3 |
| microsome format | 23 | 0 | — |
| mitochondrion format | 11 | 0 | — |
Physicochemical — 264 assays, 0 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| small-molecule physicochemical format | 248 | 0 | — |
| cell-free format | 12 | 0 | — |
| microsome format | 2 | 0 | — |
| subcellular format | 1 | 0 | — |
| tissue-based format | 1 | 0 | — |
Binding — 115 assays, 30 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 69 | 27 | 5.8 |
| cell-free format | 27 | 0 | — |
| cell-based format | 11 | 3 | 4.7 |
| organism-based format | 8 | 0 | — |
Unassigned — 36 assays, 0 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 17 | 0 | — |
| cell-based format | 12 | 0 | — |
| organism-based format | 7 | 0 | — |